Best Practice Prescribing of Controlled Substances and Drug Diversion Training
CME COST: $50
WV State Medical Association
WV Osteopathic Medical Association
WV Board of Medicine
WV Board of Osteopathic Medicine
CAMC Health Education and Research Institute
West Virginia Special 3.0 Hour CME Requirement – This program was developed and presented in cooperation with the West Virginia Board of Medicine and West Virginia Board of Osteopathic Medicine to meet the mandatory 3.0 hour CME requirement on Best Practice Prescribing of Controlled Substances and Drug Diversion Training.
The State of West Virginia Board of Pharmacy has approved the Best Practice Prescribing of Controlled Substances and Drug Diversion Training presentation under approval number WV2010-02-01-EL 3.0 DRUG DIVERSION
This material is designed to provide the primary care physician or specialty physician with an overview of topics related to proper prescribing of controlled substances and drug diversion training. Nurses, PA’s and Pharmacists may also find the material of interest. No prerequisites are required.
• List the steps needed to meet the compliance requirements under West Virginia's controlled substances laws and regulations.
• Follow the steps necessary to register, log-on and use West Virginia's controlled substance monitoring program.
• Recognize the epidemiology of chronic pain and distinguish the proper use and misuse of opioids through patient evaluations and risk assessment tools.
• Follow the proper protocol when using opioids in the treatment of chronic pain including an understanding of toxicities and drug interactions.
• Discuss West Virginia statistics on prescription drug diversion and abuse.
• Identify drug seeking tactics and behaviors and understand the 'best practice' methods to work with patients suspected of inappropriate behavior.
• Follow case studies of an evidence-based protocol for starting patients on opioid analgesic therapy, including issues specific to safely initiating and titrating opioids including treatment objectives, monitoring, referral, informed consent, agreements, urine screens, pill counts, patient education, and medical record documentation.
• The Honorable Earl Ray Tomblin, Governor, West Virginia
• Scott M. Fishman, MD, Professor and Chief, Division of Pain Medicine, Executive Vice Chair, Department of Anesthesiology and Pain Medicine, University of California, Davis School of Medicine
• Timothy Deer, MD, President and CEO, Center for Pain Relief, Inc.
• David Potters, JD, Executive Director and General Counsel, WV Board of Pharmacy
• Allen Mock, MD, MSci, DABP, FCAP, Deputy Chief Medical Examiner, WV Office of the Chief Medical Examiner
• Michael O'Neil, PharmD
• Jimmy Adams, DO, DAAPM
• Rick Vaglienti, MD